Latest Breaking News On - Sarah boyce - Page 2 : comparemela.com

Avidity Biosciences (NASDAQ:RNA) Releases Earnings Results, Beats Expectations By $0 02 EPS

Avidity Biosciences (NASDAQ:RNA – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.81) by $0.02, Zacks reports. Avidity Biosciences had a negative net margin of 2,103.78% and a negative return on equity of 37.98%. The company had revenue of […]

United statesMichaelf macleanSarah boyceAvidity biosciences incCantor fitzgeraldAvidity biosciences company profileNeedham companyAvidity biosciencesGet free reportAvidity biosciences daily

Avidity Biosciences (NASDAQ:RNA) Posts Quarterly Earnings Results, Beats Expectations By $0 02 EPS

Avidity Biosciences (NASDAQ:RNA – Get Free Report) released its quarterly earnings data on Wednesday. The biotechnology company reported ($0.79) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.81) by $0.02, Zacks reports. The company had revenue of $3.54 million during the quarter, compared to analyst estimates of $7.09 million. Avidity Biosciences had […]

United statesMichaelf macleanSarah boyceCantor fitzgeraldAvidity biosciences incNeedham companyAvidity biosciencesGet free reportBiosciences trading downChardan capitalAvidity biosciences daily

Chardan Capital Reiterates Buy Rating for Avidity Biosciences (NASDAQ:RNA)

Chardan Capital Reiterates Buy Rating for Avidity Biosciences (NASDAQ:RNA)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesSarah boyceMichaelf macleanBoard of administration florida retirement systemInvestment advisorsCantor fitzgeraldSei investments coProshare advisorsAvidity biosciences incSwiss national bankNeedham companySecurities exchange commissionAvidity biosciencesGet free reportChardan capitalBiosciences stock down

Highlights from the Django Developer Survey 2024

Highlights from the Django Developer Survey 2024
infoworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infoworld.com Daily Mail and Mail on Sunday newspapers.

Sarah boyceTim kamaninSarah abderemanePaul everittJetbrain pycharmDjango foundationDjango developerDjango developersDjango software foundationDjango board member sarah abderemaneDjango fellow sarah boyceJetbrains developer advocate paul everittHub actionsDjango developers survey

Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) for Treatment of Myotonic Dystrophy Type 1

Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC 1001) for Treatment of Myotonic Dystrophy Type 1
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSarah boyceGeoffrey grandeNavjot raiAvidity biosciences incExchange commissionEuropean medicines agencyDrug administrationAvidity biosciencesAntibody oligonucleotide conjugatesBreakthrough therapyOrphan drugFast trackOrphan designationMyotonic dystrophy type